On February 2, 2021, Mateon Therapeutics, Inc. (OTC:MATN) announced that the ARTI-19 trial of ARTIVedaâ„¢/PulmoHealâ„¢ against COVID-19 in India has completed ...
Maten Petroleum JSC Annual stock financials by MarketWatch. View the latest MATN financial statements, income statements and financial ratios.